H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Neuroscience H-index 141 Citations 75,443 1,236 World Ranking 55 National Ranking 5
Medicine H-index 159 Citations 106,597 1,811 World Ranking 289 National Ranking 6

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Gene

Henrik Zetterberg mainly investigates Pathology, Cerebrospinal fluid, Alzheimer's disease, Internal medicine and Dementia. His work carried out in the field of Pathology brings together such families of science as Biomarker and Multiple sclerosis. His Cerebrospinal fluid study combines topics in areas such as Tau protein, Csf biomarkers, Immunology and Amyloid.

In his research on the topic of Alzheimer's disease, Drug development is strongly related with Bioinformatics. His Internal medicine research incorporates elements of Gastroenterology, Endocrinology and Oncology. Disease covers Henrik Zetterberg research in Dementia.

His most cited work include:

  • Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study (1386 citations)
  • Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. (1262 citations)
  • CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. (893 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Cerebrospinal fluid, Internal medicine, Disease, Pathology and Biomarker. In Cerebrospinal fluid, Henrik Zetterberg works on issues like Amyloid, which are connected to Amyloid precursor protein. His Dementia and Alzheimer's disease investigations are all subjects of Internal medicine research.

Henrik Zetterberg combines subjects such as Apolipoprotein E and Cohort with his study of Dementia. The concepts of his Disease study are interwoven with issues in Neuroimaging, Neuroscience and Clinical trial, Bioinformatics. His work on Multiple sclerosis expands to the thematically related Pathology.

He most often published in these fields:

  • Cerebrospinal fluid (61.53%)
  • Internal medicine (52.68%)
  • Disease (43.24%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (52.68%)
  • Disease (43.24%)
  • Cerebrospinal fluid (61.53%)

In recent papers he was focusing on the following fields of study:

Henrik Zetterberg spends much of his time researching Internal medicine, Disease, Cerebrospinal fluid, Biomarker and Dementia. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology, Neurology and Oncology. His Disease research is multidisciplinary, incorporating perspectives in Clinical trial and Neuroscience.

His study on Cerebrospinal fluid is covered under Pathology. Henrik Zetterberg has included themes like Prospective cohort study, Glial fibrillary acidic protein, Cohort and Atrophy in his Biomarker study. His research in Dementia intersects with topics in Alzheimer's disease and Apolipoprotein E.

Between 2019 and 2021, his most popular works were:

  • Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (135 citations)
  • Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. (123 citations)
  • Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. (115 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Gene

The scientist’s investigation covers issues in Internal medicine, Disease, Biomarker, Cerebrospinal fluid and Dementia. His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology, Neurology and Oncology. His research investigates the connection between Disease and topics such as Differential diagnosis that intersect with issues in Retrospective cohort study.

His Biomarker research is multidisciplinary, incorporating elements of Atrophy, PRNP, Neuropathology, Prospective cohort study and Cohort. His Cerebrospinal fluid research entails a greater understanding of Pathology. His study in Dementia is interdisciplinary in nature, drawing from both Alzheimer's disease, Apolipoprotein E, Amyloid beta and Amyloid.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

Oskar Hansson;Oskar Hansson;Henrik Zetterberg;Peder Buchhave;Peder Buchhave;Elisabet Londos;Elisabet Londos.
Lancet Neurology (2006)

1867 Citations

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Kaj Blennow;Harald Hampel;Michael Weiner;Henrik Zetterberg.
Nature Reviews Neurology (2010)

1717 Citations

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen.
JAMA (2009)

1247 Citations

Defeating Alzheimer's disease and other dementias: a priority for European science and society

Bengt Winblad;Bengt Winblad;Philippe Amouyel;Sandrine Andrieu;Clive Ballard.
Lancet Neurology (2016)

1131 Citations

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Bob Olsson;Ronald Lautner;Ulf Andreasson;Annika Öhrfelt.
Lancet Neurology (2016)

1011 Citations

Clearance systems in the brain—implications for Alzheimer disease

Jenna M. Tarasoff-Conway;Roxana O. Carare;Ricardo S. Osorio;Lidia Glodzik.
Nature Reviews Neurology (2015)

783 Citations

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

Lars Lannfelt;Kaj Blennow;Henrik Zetterberg;Stellan Batsman.
Lancet Neurology (2008)

723 Citations

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

Harald Hampel;Richard Frank;Karl Broich;Stefan J. Teipel.
Nature Reviews Drug Discovery (2010)

702 Citations

Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia.

Peder Buchhave;Lennart Minthon;Henrik Zetterberg;Åsa K. Wallin.
Archives of General Psychiatry (2012)

596 Citations

The Neuropathology and Neurobiology of Traumatic Brain Injury

Kaj Blennow;John Hardy;Henrik Zetterberg;Henrik Zetterberg.
Neuron (2012)

576 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Henrik Zetterberg

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 247

Charlotte E. Teunissen

Charlotte E. Teunissen

Vrije Universiteit Amsterdam

Publications: 193

Harald Hampel

Harald Hampel

Université Paris Cité

Publications: 184

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 173

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 169

Oskar Hansson

Oskar Hansson

Lund University

Publications: 159

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 152

Leslie M. Shaw

Leslie M. Shaw

University of Pennsylvania

Publications: 142

Dag Aarsland

Dag Aarsland

King's College London

Publications: 142

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 131

David M. Holtzman

David M. Holtzman

Washington University in St. Louis

Publications: 126

Rik Ossenkoppele

Rik Ossenkoppele

Lund University

Publications: 125

Giovanni B. Frisoni

Giovanni B. Frisoni

University of Geneva

Publications: 122

William J. Jagust

William J. Jagust

Helen Wills Neuroscience Institute

Publications: 116

Michael W. Weiner

Michael W. Weiner

University of California, San Francisco

Publications: 116

Something went wrong. Please try again later.